In the UAE’s continued fight against the COVID-19 pandemic, the Ministry of Health and Prevention has now approved the Sinopharm vaccine for children aged three and above.

It was announced by the Ministry “clinical trials and extensive evaluations” had taken place in Abu Dhabi which led to the decision.

“MoHAP announced the provision of Sinopharm vaccine for the age group 3 – 17,” the National Emergency Crisis and Disaster Management Authority (NCEMA) said on Twitter. “The decision comes after clinical trials and extensive evaluations and is based on the emergency use authorization and local evaluations which are in line with the approved regulations.”

 

Following on from the NCEMA’s announcement, the Abu Dhabi Media Office issued a statement on the clinical trials on behalf of the Department of Health.

“[The Department of Health] has concluded the Sinopharm immune bridge study for children vaccination stage and continues to monitor the immune response to the vaccine in children,” the statement read.

The Department of Health also shared their thanks to the 900 children aged 3-17 and their families for taking part in the trials.

In the UAE, the Pfizer-BioNTech vaccine is also currently available for those aged between 12 to 15.

To date, 80 per cent of the UAE’s population have received their first dose of the COVID-19 vaccine and 71 per cent have received both doses.

– For more on luxury lifestyle, news, fashion and beauty follow Emirates Woman on Facebook and Instagram

Feature Image: Sara Shakeel Instagram